A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab

  • Lau, David (Primary Chief Investigator (PCI))
  • Strickland, Andrew (Chief Investigator (CI))

Project: Research

Project Details

Project Description



StatusActive
Effective start/end date28/09/21 → 27/09/26

Keywords

  • phase 3 clinical trial
  • treatment efficacy
  • treatment safety
  • advanced tumours